Alberta doctors launch CanSCAPE-HIV, warning of possible HIV resurgence after 2025 aid cuts
Alberta consortium warns of a potential HIV resurgence after 2025 aid reductions, urging faster, clearer integration of migrants into care to protect Canada’s health system.
A team of infectious-disease specialists in Alberta has formed a national consortium to sound the alarm about a possible resurgence of HIV and to push for stronger, proactive public-health measures. The newly created Canadian Strategic Consortium to Address the Changing Policies and Environment of Global HIV Care (CanSCAPE-HIV) says recent international funding shifts could reverse hard-won gains against HIV and seed new infections that may reach Canada. The group’s founders warn that early intervention and clearer pathways to care for newcomers will be essential to prevent avoidable illnesses and strain on provincial health services.
Consortium founded by Calgary infectious-disease specialists
Dr. M. John Gill and Dr. Raynell Lang, both affiliated with the University of Calgary, are leading CanSCAPE-HIV to coordinate research, advocacy and policy proposals. The consortium brings together clinicians, researchers and community organizers to assess evolving global risks and to prepare Canada’s public-health response. Its stated aim is to develop practical recommendations for federal and provincial governments that reduce barriers to care for people living with HIV who arrive in Canada.
CanSCAPE-HIV’s founders stress that the consortium is both a research body and an advocacy network, designed to translate modeling and field evidence into actionable public-health steps. They argue that Canada can blunt the local impact of global developments by improving screening follow-up, expanding information for newcomers and simplifying access to antiretroviral therapy.
Global aid cuts in 2025 linked to rising infection models
The consortium points to international policy changes that began in January 2025, when major reductions in global HIV funding were implemented by several donor governments. CanSCAPE-HIV says epidemiological models using recent program data indicate that scaled-back prevention and treatment services in lower‑resource countries could produce higher transmission rates over the next several years. Those elevated rates, the group warns, increase the probability that people with newly acquired or untreated HIV will migrate, travel or seek refuge abroad.
Experts within the consortium underscore that prevention and treatment are most cost‑effective when delivered early in countries where incidence is rising. They say collapsing programs overseas can lead to treatment interruptions, loss of viral suppression and widening transmission—conditions that are more expensive and difficult to address once infections spread.
Challenges facing newcomers diagnosed at immigration
Under Canada’s immigration medical process, newcomers may be tested for HIV but a positive result does not bar admission. CanSCAPE-HIV members describe a recurring problem: migrants often receive only a short supply of antiretroviral medication upon arrival and must quickly navigate unfamiliar health systems to maintain uninterrupted treatment. For people coming from countries where HIV carries heavy stigma or legal penalties, fear of disclosure and misunderstanding about Canadian protections can delay engagement in care.
The consortium is asking federal and provincial authorities to provide clearer information at ports of entry and during settlement services so that people who test positive can confidentially connect to community clinics and provincial drug coverage without fear. Simplified referral pathways, multilingual materials and partnerships with settlement agencies are among the practical solutions CanSCAPE-HIV has proposed.
Cost implications for provincial health systems
CanSCAPE-HIV warns that treating stable, virally suppressed people living with HIV costs far less than managing advanced, untreated disease. Current outpatient antiretroviral regimens for many patients translate into monthly medication costs that can approach $1,500, according to estimates cited by clinicians. The consortium argues that late diagnosis, treatment interruption and progression to AIDS result in far higher downstream costs, including hospitalizations and complex co‑morbid care.
Public-health planners are being urged to consider preventive investments—such as outreach, testing, and linkage-to-care programs for newcomers—as cost-saving measures in the medium term. The consortium contends that supporting immediate access to therapy upon arrival will protect individuals’ health and reduce strain on emergency departments and inpatient services.
Data and recommendations for federal and provincial action
CanSCAPE-HIV points to national surveillance estimates to illustrate the scale of the issue: in 2022 the Canadian AIDS Treatment Information Exchange (CATIE) reported about 65,270 people living with HIV in Canada, with roughly 7,050 estimated to be undiagnosed and untreated. The consortium wants those numbers reduced through targeted outreach to communities at higher risk, improved communication during settlement, and coordinated federal-provincial programs that ensure continuity of care.
Among the group’s concrete asks are better-funded newcomer health navigators, rapid enrollment in provincial drug programs, expanded community clinic hours, and standardized intake protocols that protect confidentiality and remove misconceptions about immigration consequences. CanSCAPE-HIV also calls for increased surveillance and modeling to track the impact of international funding changes on migration-related transmission risks.
The consortium is preparing to present a policy brief to federal and provincial health ministries and to seek partnerships with community organizations and primary-care networks. Its leaders say timely political attention and modest investments now could avert a more costly public‑health crisis later.
Public-health officials and policymakers have limited time to act if the models prove accurate, the consortium warns. By strengthening entry-point care and eliminating barriers for newcomers living with HIV, Canada can protect individual well‑being and the resilience of its health system while contributing to global efforts to keep HIV under control.
